🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

PRECIOUS-Gold rebounds as dollar eases; virus treatment hopes cap gains

Published 08/24/2020, 06:29 PM
Updated 08/24/2020, 08:50 PM
© Reuters.
XAU/USD
-
XAG/USD
-
GC
-
SI
-
DXY
-

* Global equities gain for second session
* Investors eye Fed Chair's address at Jackson Hole
* Interactive graphic tracking global spread of coronavirus:
open
https://tmsnrt.rs/3aIRuz7 in an external browser

(Updates prices)
By Diptendu Lahiri
Aug 24 (Reuters) - Gold prices rose on Monday as the dollar
dipped, making bullion cheaper for holders of other currencies,
but hopes for progress in the treatment of COVID-19 limited
gains in the safe-haven metal.
Spot gold XAU= was up 0.4% at $1,946.89 an ounce by 1240
GMT, having jumped 1% to $1,961.40 an ounce after early losses.
U.S. gold futures GCv1 gained 0.8% to $1,961.80.
"The dollar is softer today and, if we look at the larger
picture, the world economy is still trying to recover from the
effects of coronavirus," said Saxo Bank analyst Ole Hansen.
"Along with that, the risk of inflation continues to attract
investors to gold."
The dollar index .DXY was down 0.4% after climbing to a
more than one-week high in the previous session.
Investors are awaiting U.S. Federal Reserve Chairman Jerome
Powell's address to the bank's annual symposium in Jackson Hole,
Wyoming, on Thursday for signs of how aggressively it will seek
to handle the long-term recovery from the pandemic. "The U.S. central bank should reiterate its pledge for
ultra-low rates, providing some support for gold," Avtar Sandu,
a senior commodities manager at Phillip Futures, said in a note.
"(It) may be expected to signal greater tolerance for
above-target inflation, keeping real interest rates low."
Lower U.S. interest rates cut the opportunity cost of
holding non-yielding bullion.
Central banks worldwide have rolled out massive stimulus
measures to alleviate the economic damage caused by the COVID-19
pandemic, but that has also increased the probability of rising
inflation.
Restricting gold's advance, equity markets gained for a
second straight session after the U.S. Food & Drug
Administration authorised the use of blood plasma from patients
who have recovered from COVID-19 as a treatment for the disease.
MKTS/GLOB
Silver XAG= rose 0.8% to $26.90 an ounce, platinum XPT=
was up 0.6% at $924.29 and palladium XPD= eased 0.1% to
$2,180.18.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.